Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Rating) – William Blair issued their Q1 2023 earnings per share (EPS) estimates for Rocket Pharmaceuticals in a note issued to investors on Wednesday, March 22nd. William Blair analyst S. Corwin forecasts that the biotechnology company will post earnings of ($0.96) per share for the quarter. William Blair has […]
William Blair restated their outperform rating on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Get Rating) in a research report report published on Wednesday, PriceTargets.com reports. Several other equities research analysts have also issued reports on the company. StockNews.com assumed coverage on Rocket Pharmaceuticals in a research report on Thursday, March 16th. They set a sell […]
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Rating) gapped down before the market opened on Tuesday following a dissappointing earnings announcement. The stock had previously closed at $18.46, but opened at $17.81. Rocket Pharmaceuticals shares last traded at $18.85, with a volume of 71,606 shares traded. The biotechnology company reported ($0.92) EPS for the […]